18F-Fluciclovine, a radiolabeled synthetic amino acid that targets both ASCT2 and LAT1, is already used for localizing prostate cancer [26] and has been explored for imaging glioblastoma [27]. The gene discussed is SLC1A5; the disease is prostate cancer.